A Study of Gentuximab + Paclitaxel in Patients With Advanced Gastric or Gastroesophageal Junction Cancer
Clinical trial NCT04053205 · COMPLETED
Trial details
- NCT number
- NCT04053205
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-05
- Primary completion
- 2020-06-01
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.